HOME >> BIOLOGY >> NEWS
NJIT mathematician receives Fulbright to study thin film science in Argentina

ations will be performed on a large computer located at NJIT, purchased with funds from the National Science Foundation.

This kind of work is often referred to as mathematical modeling. Mathematical modelers, like Kondic, formulate mathematical equations that are believed to describe physical, biological, or sociological phenomena. The modelers take the known and accepted formulas of physics and/or chemistry and create mathematical equations that described unexplained phenomenon--such as why two fluids may adhere. While mathematical modeling may not always validate a fundamental physical or chemical principle, if the answer matches most of the presumed data, then researchers know they may be on the right path. Scientists in many fields, including biology, chemistry, physics, and engineering use mathematical modeling in their research. Economists, sociologists, and political scientists also utilize sophisticated mathematical modeling to deal with detailed problems associated with human behavior.

Kondic is the author of more than 50 research articles. His most recent scholarly article, "On Nontrivial Traveling Waves in Thin Film Flows, Including Contact Lines" appeared in September of 2005 in Physica D. The National Science Foundation, NASA and the International Exchange of Scholars have supported Kondic's work. Kondic received his doctorate in physics from City College of City University of New York.


'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
2-Dec-2005


Page: 1 2

Related biology news :

1. York mathematician probes geometric route to combat viruses
2. UCLA biomathematician earns prestigious peer award
3. Delft mathematician enhances protectiveness of military uniform
4. NJIT mathematician receives noted math prize
5. Carnegie Mellons Peter Adams receives EPA research grant
6. Philadelphia ecologist receives top Mongolia honor
7. VIB scientist receives major research grant
8. Maynard Olson receives $500,000 Gruber Genetics Prize
9. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
10. Wright State scientist receives grant to help clean up polluted American harbors
11. UCR biologist receives $1.75 million grant to study plant-threatening bacteria

Post Your Comments:
(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: